[ad_1]
DexCom DXCM reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
DexCom missed estimated earnings by 10.53%, reporting an EPS of $0.17 versus an estimate of $0.19.
Revenue was up $97.10 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 1.13% drop in the share price the next day.
Here’s a look at DexCom’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.13 | 0.21 | 0.16 | 0.11 |
| EPS Actual | 0.08 | 0.17 | 0.22 | 0.19 |
| Revenue Estimate | 623.36M | 695.63M | 617.82M | 551.27M |
| Revenue Actual | 628.80M | 698.20M | 650.20M | 595.10M |
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.13 | 0.21 | 0.16 | 0.11 |
| EPS Actual | 0.08 | 0.17 | 0.22 | 0.19 |
| Revenue Estimate | 623.36M | 695.63M | 617.82M | 551.27M |
| Revenue Actual | 628.80M | 698.20M | 650.20M | 595.10M |
To track all earnings releases for DexCom visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.